Shionogi & Co., Ltd. (OTCMKTS:SGIOY) Sets New 12-Month Low at $9.55

Shionogi & Co., Ltd. (OTCMKTS:SGIOY) shares reached a new 52-week low during trading on Thursday . The stock traded as low as $9.55 and last traded at $9.55, with a volume of 410089 shares changing hands. The stock had previously closed at $9.68.

Shionogi & Co., Ltd. Stock Down 0.1 %

The firm has a 50 day simple moving average of $11.34 and a two-hundred day simple moving average of $11.95. The stock has a market cap of $11.32 billion, a P/E ratio of 9.85, a P/E/G ratio of 2.66 and a beta of 0.25. The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.03 and a current ratio of 5.86.

Shionogi & Co., Ltd. (OTCMKTS:SGIOY) last issued its earnings results on Monday, May 13th. The company reported $0.21 earnings per share (EPS) for the quarter. Shionogi & Co., Ltd. had a net margin of 37.29% and a return on equity of 13.20%. The business had revenue of $662.08 million during the quarter. Equities research analysts predict that Shionogi & Co., Ltd. will post 0.87 earnings per share for the current year.

Shionogi & Co., Ltd. Company Profile

Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug.